1. Home
  2. GLOB vs AAPG Comparison

GLOB vs AAPG Comparison

Compare GLOB & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globant S.A.

GLOB

Globant S.A.

N/A

Current Price

$41.60

Market Cap

1.3B

Sector

Technology

ML Signal

N/A

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

N/A

Current Price

$11.97

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GLOB
AAPG
Founded
2003
2009
Country
Luxembourg
China
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2015
2024

Fundamental Metrics

Financial Performance
Metric
GLOB
AAPG
Price
$41.60
$11.97
Analyst Decision
Buy
Strong Buy
Analyst Count
23
11
Target Price
★ $52.10
$44.50
AVG Volume (30 Days)
★ 1.0M
5.3K
Earning Date
11-19-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$17.91
Revenue Next Year
$1.28
$111.96
P/E Ratio
$22.55
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.56
$12.44
52 Week High
$72.10
$33.09

Technical Indicators

Market Signals
Indicator
GLOB
AAPG
Relative Strength Index (RSI) 40.75 28.67
Support Level $34.29 N/A
Resistance Level $44.64 $16.28
Average True Range (ATR) 2.16 0.38
MACD -1.09 -0.27
Stochastic Oscillator 12.42 0.00

Price Performance

Historical Comparison
GLOB
AAPG

About GLOB Globant S.A.

Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: